Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
C.I. MEDICAL, Jul-Sep (3Q) Ordinary Profit Increases by 3.9 times
3540 C.I. MEDICAL CO.,LTD. 【J-GAAP】
Earnings ReportC.I. MEDICAL CO.,LTD. <3540> [TSE Std] announced its financial results after the market closed on November 12th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending December 2025 (January to September) surged 2.7 times that of the same period last year, reaching 3.49 billion yen. Progress toward the full-year plan of 4.54 billion yen was 77.0%, also surpassing the five-year average of 71.8%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to December period (4Q) is expected to decrease 22.0% from the same period last year to 1.04 billion yen.
In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit surged 3.9 times that of the same period last year, reaching 1.23 billion yen. The operating profit margin significantly improved from 0.6% in the same period last year to 5.2%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Sep, 2023 | 33,648 | 2,548 | 2,752 | 1,739 | 34.8 | 83.5 | Nov 13, 2023 | J-GAAP |
| Jan - Sep, 2024 | 45,248 | 1,108 | 1,285 | 5,337 | 106.8 | 49.0 | Nov 12, 2024 | J-GAAP |
| Jan - Sep, 2025 | 69,121 | 3,321 | 3,498 | 3,208 | 64.2 | 77.0 | Nov 12, 2025 | J-GAAP |
| YoY | +52.8% | +199.7% | +172.2% | -39.9% | -39.9% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 | 43,177 | 1,510 | 1,650 | 5,689 | 113.8 | 12.53 | Feb 12, 2025 | J-GAAP |
| Jul - Dec, 2025 Guidance | 53,867 | 2,255 | 2,280 | 1,533 | 30.7 | 0 | Aug 7, 2025 | J-GAAP |
| YoY | +24.8% | +49.3% | +38.2% | -73.1% | -73.1% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 45,628 | 2,989 | 3,295 | 2,082 | 41.7 | 5.04 | Feb 13, 2024 | J-GAAP |
| Dec, 2024 | 67,493 | 2,493 | 2,621 | 6,266 | 125.3 | 12.53 | Feb 12, 2025 | J-GAAP |
| Dec, 2025 Guidance | 100,000 | 4,380 | 4,540 | 4,000 | 80.0 | 0 | Aug 7, 2025 | J-GAAP |
| YoY | +48.2% | +75.7% | +73.2% | -36.2% | -36.2% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 20,932 | 125 | 314 | 4,760 | 95.2 | 0.6 | Nov 12, 2024 | J-GAAP |
| Oct - Dec, 2024 | 22,245 | 1,385 | 1,336 | 929 | 18.6 | 6.2 | Feb 12, 2025 | J-GAAP |
| Jan - Mar, 2025 | 22,657 | 708 | 806 | 1,367 | 27.4 | 3.1 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 23,476 | 1,417 | 1,454 | 1,100 | 22.0 | 6.0 | Aug 7, 2025 | J-GAAP |
| Jul - Sep, 2025 | 22,988 | 1,196 | 1,238 | 741 | 14.8 | 5.2 | Nov 12, 2025 | J-GAAP |
| YoY | +9.8% | +856.8% | +294.3% | -84.4% | -84.4% |
Related Articles
UMC Electronics, Jul-Sep (2Q) Ordinary Profit Turns to Profit
Carlit, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 10%, Highest in Two Terms, Dividend Revised Upward by 2 Yen
FALTEC, First Half Ordinary Profit Decreases by 36%
Broadleaf, Jul-Sep (3Q) Net Income Increases by 2.6 times
Solasto, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 15%
IBJ, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 12%, Raises Record High Profit Forecast, Dividend Revised Upward by 2 Yen
Photosynth, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 90%, Exceeds Full-Year Plan
KIMURATAN, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 56%
CROOZ, The Current Fiscal Year's Undisclosed Ordinary Loss to Narrow
Finatext Holdings, First Half Ordinary Profit Decreases by 13%, Jul-Sep Ordinary Profit Decreases by 43%